Turn Therapeutics Inc. (TTRX:NASDAQ) closed at $9.35 on November 13, 2026, down 7.75% on the day. The stock trades 43.2% below its 52-week high of $16.45 and 263.6% above its 52-week low of $2.57. Over the past year, it gained 167.0%. Turn Therapeutics Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, TTRX closed higher on 128 days (51%). Its best day was September 8, 2026 (+29.18%) and its worst was December 8, 2025 (-21.81%). The stock moved 10% or more in a single session 18 times. It opened at least 5% above the previous day's high 3 times.
Turn Therapeutics is a pharmaceutical and medical device development company built around a proprietary platform technology designed to enhance drug performance. Our patented mixing process commercially referred to as PermaFusion enables stable suspension of polar watersoluble active pharmaceutical ingredients APIs in oilbased carriers without the use of emulsifiers. This innovation reduces the quantity of required API inclusion by improving its bioavailability. Reduced API load reduces the likelihood of adverse events. Our proprietary platform has been validated across multiple FDA cleared medical devices. Our primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis.
Find more stocks like TTRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.